Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2026-01-22 @ 10:13 PM
Study NCT ID:
NCT00669318
Status:
COMPLETED
Last Update Posted:
2014-07-01
First Post:
2008-04-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor:
Organization: